[Laboratory control of fibrinolytic therapy]
- PMID: 2427412
[Laboratory control of fibrinolytic therapy]
Abstract
The mode of action of the different thrombolytic substances which are presently available is described. Alterations of the clotting mechanism which are to be expected during thrombolytic therapy as well as possible side effects of the fibrinolytic drugs are listed. Laboratory tests necessary for the control of thrombolytic therapy as well as the different test methods and their normal ranges are mentioned in detail.
Similar articles
-
[Position and developmental trends in fibrinolytic therapy].Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113(1-2):6-17. Folia Haematol Int Mag Klin Morphol Blutforsch. 1986. PMID: 2427416 German.
-
Fibrinolysis--a review.Ann Clin Lab Sci. 1984 Nov-Dec;14(6):443-9. Ann Clin Lab Sci. 1984. PMID: 6239587 Review.
-
An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.Prog Hemost Thromb. 1984;7:325-56. Prog Hemost Thromb. 1984. PMID: 6241729 Review. No abstract available.
-
[Tissue plasminogen activator: mechanism of action and thrombolytic properties].Sangre (Barc). 1984;29(4-C):767-73. Sangre (Barc). 1984. PMID: 6393389 Review. Spanish. No abstract available.
-
[New thrombolytic drugs].Pol Tyg Lek. 1990 Feb 5-12;45(6-7):127-30. Pol Tyg Lek. 1990. PMID: 2216951 Polish. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical